Shanghai Taichu Biotechnology
A company leading the non-clinical research of new drugs to Contract Development and Manufacturing Organization (CDMO) production.
Launch date
Market cap
-
Enterprise valuation
$193—289m (Dealroom.co estimates May 2023.)
Shanghai China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
N/A | Seed | ||
CNY300m | Seed | ||
* | CNY350m | Series A | |
| Total Funding | $89.4m | ||